Expert Insights On Data Management & Analysis

  1. Best Practices For Complete Registration And Reporting Of Summary Results On ClinicalTrials.gov 3/5/2024

    The Clinical Trials Transformation Initiative (CTTI), alongside the FDA, investigated factors and barriers to registration and summary results information reporting. Here is what they found and what they suggest for ensuring complete reporting of trial results.

  2. Leveraging AI For Data Analysis In Pharmacy-Based Trials 2/28/2024

    Leveraging AI for data analysis in pharmacy-based trials holds immense potential for revolutionizing drug development and healthcare delivery.

  3. Making Rare Disease Progress With Novel Strategies, Data Standardization, And More 2/14/2024

    The integration of innovative research methodologies, coupled with the standardization of data and use of advanced visualization techniques, represents a holistic strategy to address the complexities of rare diseases.

  4. 9 Ways Unified Clinical Data Cloud Platforms Solve Data Challenges In Rare Disease 2/8/2024

    A unified clinical data cloud platform is a data and analytics platform that contains a data hub to aggregate clinical data from multiple data sources and in multiple formats — and it could be the cure for disordered rare disease data.

  5. Digitizing The Clinical Protocol: Small Steps For Seismic Change 1/30/2024

    A proliferation of clinical trial platform systems has meant increased friction for data exchange. Discover how TransCelerate is tackling this problem with small steps that yield big results.

  6. Objectively Evaluating Innovative Therapies And Making Sense Of Emerging Data 1/22/2024

    Poseida Therapeutics' President and CEO, Kristin Yarema, Ph.D., details why allogenic CAR-T compares favorably with autologous CAR-T, and why, in many ways, allo has advantages that auto cannot hope to match.

  7. AI In Drug Discovery And Development — Will It Live Up To The Hype? 1/5/2024

    While AI may soon transform the drug discovery and development process, there are still several barriers, both technical and ethical, to the rise of AI in biopharma.

  8. What Clinical Trial Experts Think Will Happen With AI In 2024 12/26/2023

    In part one of this preview of clinical trials trends for 2024, experts discuss the applications of AI in clinical research.

  9. WHO's 6 Principles For An AI Regulatory Framework For Medical Product Development 12/14/2023

    In mid-Oct. 2023, the WHO published a paper titled Regulatory Considerations on Artificial Intelligence for Health, identifying the key principles that international regulatory frameworks for artificial intelligence (AI) should address and are, in fact, starting to coalesce around. The paper was developed in consultation with a WHO Working Group whose members include regulatory authorities, policy makers, and more.

  10. Pacesetters Are Product Innovators Who Embrace Digital Process Enhancement 12/12/2023

    The Josh Bersin Company recently underwent research examining pharma/biotech “pacesetters” in the field. We caught up with Jordan Schmitting, senior research analyst at The Josh Bersin Company, to discuss the trends illuminated by the research.